Inhibition of topoisomerase I activity and efflux drug transporters’ expression by xanthohumol from hops
- 218 Downloads
Xanthohumol (XN) and its related compounds were evaluated for their cytotoxicity against four different human cancer cell lines, A549 (lung), SK-OV-3 (ovarian), SK-MEL-2 (melanoma), and HCT-15 (colon) using a sulforhodamine B assay. XN showed the most active cytotoxicity against the human cancer cell lines. Isoxanthohumol, 8-prenylnaringenin, and xanthohumol 4’-O-β-D-glucopyranoside showed comparable cytotoxicity and (2S)-5-methoxy-8-prenylnaringe-nin 7-O-β-D-glucopyranoside was the least cytotoxic compound. The anticancer properties of XN, the most active cytotoxic compound, were further investigated. XN showed an inhibitory effect on the activity of DNA topoisomerase I (topo I), which was measured from the relaxation of supercoiled DNA. The inhibition of topo I by XN might explain the cytotoxicity against the human cancer cell lines. Moreover, the expression of the drug efflux genes was investigated to predict the drug resistance. XN clearly decreased the mRNA levels of ABCB1 (MDR1), ABCC1 (MRP1), ABCC2 (MRP2), and ABCC3 (MRP3). These results suggest that XN has anticancer properties by inhibiting the topo I activity and it might be used in conjunction with other anticancer chemotherapeutic agents to reduce the drug resistance inhibiting the efflux drug transporters.
Key wordsXanthohumol Cytotoxicity Topoisomerase I Efflux drug transporter Cancer
Unable to display preview. Download preview PDF.
- Dietz, B. M., Kang, Y. H., Liu, G., Eggler, A. L., Yao, P., Chadwick, L. R., Pauli, G. F., Farnsworth, N. R., Mesecar, A. D., van Breemen, R. B., and Bolton, J. L., Xanthohumol isolated from Humulus lupulus Inhibits menadione-induced DNA damage through induction of quinone reductase.Chem. Res. Toxicol., 18, 1296–1305 (2005).PubMedCrossRefGoogle Scholar
- Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., Baas, F., and Borst, P., Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.Cancer Res., 57, 3537–3547 (1997).PubMedGoogle Scholar
- Liu, G., Eggler, A. L., Dietz, B. M., Mesecar, A. D., Bolton, J. L., Pezzuto, J. M., and van Breemen, R. B., Screening method for the discovery of potential cancer chemoprevention agents based on mass spectrometric detection of alkylated Keap1.Anal. Chem., 77, 6407–6414 (2005).PubMedCrossRefGoogle Scholar
- Miranda, C. L., Stevens, J. F., Helmlich, A., Henderson, M. C., Rodriguez, R. J., Yang, Y. H., Deinzer, M. L., Barnes, D. W., and Buhler, D. R., Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines.Food Chem. Toxicol., 37, 271–285 (1999).PubMedCrossRefGoogle Scholar
- Miranda, C. L., Yang, Y. H., Henderson, M. C., Stevens, J. F., Santana-Rios, G., Deinzer, M. L., and Buhler, D.R., Prenyl- flavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4, 5-f]quinoline, mediated by cDNA-expressed human CYP1A2.Drug Metab. Dispos., 28, 1297–1302 (2000).PubMedGoogle Scholar